argatrobanheparin-induced thrombocytopeniaICUHIThepatic dysfunctionExtracorporeal supportECMO
…e the impact of organ dysfunction and extracorporeal support on argatroban dosing requirements in critically ill patients.Material and Met…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 195 of 2459fluoxetinecitalopramvenlafaxineduloxetinesertralineescitalopramamitriptylinecancerPubMedCochrane+2 more
…arratively.Results Eight studies met inclusion criteria. SSRIs (fluoxetine, sertraline, escitalopram, citalopram) consistently improved de…
renal failureHAMCCPWHOdyselectrolytaemiaHigh alert medicationsAPAnon-monographic tertiary care hospital
… 2025. Said APA lists patients according to clinical variables (renal failure, dyselectrolytaemia, etc.) and prescription reconciliation vari…
ipilimumabmelanomanivolumabtocilizumabmycophenolate mofetilinfliximabvedolizumabEastern Cooperative Oncology Group
…everity, and management of irAEs in melanoma patients receiving ipilimumab–nivolumab therapy.Material and Methods A retrospective observat…
piperacillin-tazobactamvancomycinliposomal amphotericin Blinezolidvoriconazoledaptomycincarbapenemsmeropenemregional hospitalsInternal Medicine+3 more
…e following antimicrobials under special control were reviewed: piperacillin-tazobactam, carbapenems, vancomycin, linezolid, daptomycin, voriconazole, …
clothiapinelevomepromazinerisperidonelevetiracetamphenobarbitalquetiapinevalproateclonazepamolanzapineintellectual disabilities+1 more
…mepromazine (14.5%), olanzapine (12.7%), quetiapine (10.4%) and clothiapine (9%). Point out that 59.09% of residents take one antipsychotic…
venetoclaxibrutinibzanubrutinibacalabrutinibchronic lymphocytic leukaemiaCLLBTKiBCL2i
…brutinib (40.7%), acalabrutinib (30.5%), zanubrutinib (3.4%) or venetoclax (25.4%). 91.5% of them had at least one comorbidity and the med…
pembrolizumabdurvalumabdostarlimabtremelimumabnivolumabatezolizumabcemiplimabavelumabipilimumabimmunotherapy+2 more
…Results In 2023 and 2024 we used seven immunotherapeutic drugs: pembrolizumab (230 patients), durvalumab (45 patients), atezolizumab (45 pati…
ruxolitinibmomelotinibfedratinibPalandri et al.MPNmyelofibrosisPhiladelphia-negative chronic myeloproliferative neoplasms
…tudy was conducted including all patients with MPN treated with ruxolitinib. Demographic, clinical, and disease evolution variables were co…
QuetiapinedementiaBenzodiazepinesBladder antimuscarinicsAGUStatinsSTOPPCogOpioids
…nsives 10 (20.8%) Opioids 10 (20.8%) D1 Opiods for chronic pain Quetiapine 9 (18.8%) A5 First and second-generation antipsychotics (antich…
insulinsOACInstitute for Safe Medication PracticesdigoxinopioidsbenzodiazepinesHAM-HHAMschronic pathology
…ineoplastic/immunomodulators) =2.9%. Drugs mainly involved were insulins (22.9%), benzodiazepines (20.0%), OAC (11.4%), opioids (8.6%), …
linezolidtigecyclineechinocandinsdaptomycinaztreonammeropenemAntimicrobial resistanceertapenemvancomycinsepsis+6 more
… were reviewed, mainly meropenem (39.7%), ertapenem (21.2%) and linezolid (6.2%). Most treatments were empirical (52.4%) or targeted (42.…